Ildong Pharmaceutical Supplies Rapigen COVID-19 Rapid Antigen Test Kits
CEO Jaegu Park of Rapigen and CEO Woongseop Yoon of Ildong Pharmaceutical (from left in the photo) are posing for a commemorative photo after signing a supply contract for the professional rapid antigen test kit 'BioCredit COVID-19 Ag'. (Photo by Ildong Pharmaceutical)
View original image[Asia Economy Reporter Chunhee Lee] Ildong Pharmaceutical will be responsible for supplying Rapigen's COVID-19 professional rapid antigen test kit, 'BioCredit COVID-19 Ag.'
Hot Picks Today
"Do We Need to Panic Buy Again?" War Drives 30% Price Surge... Even the Bedroom Feels the Impact
- "Suspicious Timing?"...Trump Traded Stocks After Praising Wartime Capabilities
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Contact Me First If Houses Are Built": Wealthy Clients Eyeing... Will Ultra-High-End Residences Worth 20 Billion Won Be Developed? [Real Estate AtoZ]
On the 7th, Ildong Pharmaceutical announced that it had signed a supply contract with Rapigen for BioCredit COVID-19 Ag. Accordingly, Ildong Pharmaceutical will handle the distribution of this product to hospitals and clinics. Additional discussions will also be held regarding the distribution of over-the-counter (OTC) self-test kits available at pharmacies.
?
BioCredit COVID-19 Ag is a professional COVID-19 antigen test kit developed by Rapigen. It is an in vitro diagnostic medical device that helps diagnose COVID-19 infection by detecting the SARS-CoV-2 antigen in nasopharyngeal swab specimens of the test subject using an immunochromatography method.
?
Rapigen explained that the test kit applies its proprietary technology, 'Black Gold Nanoparticles,' enabling stable results within 15 to 30 minutes without the need for separate laboratories or equipment. Additionally, by applying a dual-color system, the test line appears black during result interpretation, enhancing user readability. Rapigen also stated that through multiple clinical trials, the kit has achieved sensitivity above 90% and specificity above 99% in terms of accuracy.
?
An Ildong Pharmaceutical official said, “As COVID-19 prevention guidelines have recently changed, symptomatic individuals are now being diagnosed at respiratory specialty hospitals, causing a surge in demand for professional rapid antigen test kits. We will focus our capabilities on stable supply to support quick and accurate testing.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
